| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.31 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.28 | 0.08 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.27 | 0.09 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.23 | 0.3 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.22 | 0.3 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.19 | 0.4 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.16 | 0.4 |